{"id":"W4385459489","doi":"10.1101/2023.07.30.23293383","title":"A protocol for a systematic review with prospective individual patient data meta-analysis in EGFR mutant NSCLC with brain metastases to assess the effect of SRS + Osimertinib compared to Osimertinib alone: the STARLET collaboration","year":2023,"lang":"en","type":"review","venue":"medRxiv","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency","funders":"National Medical Research Council; Medical Research Council; Victorian Cancer Agency; National University Health System; Cancer Australia; Seagen; BeiGene; Elekta; BC Cancer Agency; National University Cancer Institute, Singapore; AstraZeneca; Yuhan; Pfizer; Amgen","keywords":"Osimertinib; Medicine; Oncology; Internal medicine; Lung cancer; Clinical endpoint; Radiosurgery; Clinical trial; Meta-analysis; Randomized controlled trial; Adverse effect; Population; Erlotinib; Epidermal growth factor receptor; Cancer; Radiation therapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08492366,0.006256862,0.02031281,0.01048947,0.003203211,0.007344401,0.005318836,0.008265552,0.129952],"category_scores_gemma":[0.144041,0.005064634,0.0232871,0.01167549,0.003831315,0.007146036,0.005049667,0.007125597,0.01322433],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01181205,"about_ca_system_score_gemma":0.03259215,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004656692,"about_ca_topic_score_gemma":0.009749074,"domain_scores_codex":[0.9419912,0.03137173,0.01468831,0.005328908,0.00484882,0.001770999],"domain_scores_gemma":[0.9226344,0.03666856,0.01494502,0.01087083,0.01252472,0.00235652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01249786,0.000190966,0.0006020206,0.8935952,0.01033809,0.0003330215,0.0008530912,0.001321893,0.00119751,0.005105061,0.05335581,0.0206095],"study_design_scores_gemma":[0.1137589,0.002165049,0.005790754,0.5018981,0.03239338,0.0005298635,0.0009999874,0.003863725,0.002344709,0.02461098,0.3108486,0.0007959945],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.0005085264,0.00246571,0.00307612,0.001005813,0.0008505772,0.9694325,0.02098856,0.0004268143,0.001245342],"genre_scores_gemma":[0.0005086592,0.0004642304,0.003636366,0.0002829479,0.00003978549,0.9936463,0.0009557834,0.0000293043,0.0004367671],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.129952,"threshold_uncertainty_score":0.4491246,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.196984723913741,"score_gpt":0.4416677691690117,"score_spread":0.2446830452552707,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}